Effects of Certain Nucleoside Analogues on Human Cytomegalovirus Replication in vitro

References

1. Camiener G. W. 1968; Studies of the enzymatic deamination of aracytidine. V. Inhibition in vitro and in vivo by tetrahydrouridine and other reduced pyrimidine nucleosides. Biochemical Pharmacology 17:1981–1991
   [Google Scholar]
2. Cheng Y. C., Dutschman G., Fox J. J., Watanabe K. A., Machida H. 1981; Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinase. Antimicrobial Agents and Chemotherapy 20:420–423
   [Google Scholar]
3. Chou T. C., Lopez C., Colacino J. M., Philips F. S. 1980; Metabolism and effects of 2′-fluoro-5-iodo-l-β-d-arabinofuranosylcytosine (FIAC) in human leukemic and virus-infected Vero cells. Proceedings of the American Association for Cancer Research 21:269
   [Google Scholar]
4. Cohen R. M., Wolfenden R. 1971; Cytidine deaminase from Escherichia coli. Purification, properties, and inhibition by the potential transition state analog 3, 4, 5, 6-tetrahydrouridine. Journal of Biological Chemistry 246:7561–7565
   [Google Scholar]
5. Crumpacker C. S., Schnipper L. E., Zaia J. A., Levin M. J. 1979; Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrobial Agents and Chemotherapy 15:642–645
   [Google Scholar]
6. Elion G. B., Furman P. A., Fyfe J. A., Demiranda P., Beauchamp L., Schaeffer H. J. 1977; Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proceedings of the National Academy of Sciences, U. S. A 74:5716–5720
   [Google Scholar]
7. Estes J., Huang E. S. 1977; Stimulation of cellular thymidine kinase by human cytomegalovirus. Journal of Virology 24:13–21
   [Google Scholar]
8. Fox J. J., Lopez C., Watanabe K. A. 1981; 2′-Fluoro-arabinosyl pyrimidine nucleosides: chemistry, antiviral, and potential anticancer activities. In Medicinal Chemistry Advances pp 27–40 Edited by De Las Heras F. G., Vega S. Oxford & New York: Pergamon Press;
   [Google Scholar]
9. Gillespie D., Spiegelman S. 1965; A quantitative assay for DNA-RNA hybrids with DNA immobilized on a membrane. Journal of Molecular Biology 12:829–842
   [Google Scholar]
10. Hanze A. R. 1967; Nucleic acids. IV. The catalytic reduction of pyrimidine nucleosides (human liver deaminase inhibition). Journal of the American Chemical Society 89:6720–6725
    [Google Scholar]
11. Huang E. S. 1975; Human cytomegalovirus. IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid. Journal of Virology 16:1560–1565
    [Google Scholar]
12. Huang E. S., Chen S. T., Pagano J. S. 1973; Human cytomegalovirus. I. Purification and characterization of viral DNA. Journal of Virology 12:1473–1481
    [Google Scholar]
13. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
14. Lopez C., Livelli T., Watanabe K., Reichman U., Fox I. J. 1979; ′-Fluoro-5-iodo-aracytosine: a potent antiherpesvirus nucleoside with minimum toxicity to normal cells. Proceedings of the American Association for Cancer Research 20:183
    [Google Scholar]
15. Lopez C. K., Watanabe K. A., Fox J. J. 1980; 2′-Fluoro-5-iodo-aracytosine, a potent and selective antiherpesvirus agent. Antimicrobial Agents and Chemotherapy 17:803–806
    [Google Scholar]
16. Mar E. C., Patel P. C., Huang E. S. 1981; Human cytomegalovirus-associated DNA polymerase and protein kinase activities. Journal of General Virology 57:149–156
    [Google Scholar]
17. Mar E. C., Patel P. C., Huang E. S. 1982; Effect of 9-(2-hydroxyethoxymethyl)guanine on viral-specific polypeptide synthesis in human cytomegalovirus-infected cells. American Journal of Medicine 73:82–85
    [Google Scholar]
18. Neil G., Moxley T., Manak R. 1970; Enhancement by tetrahydrouridine of I-/J-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice. Cancer Research 30:2166–2172
    [Google Scholar]
19. Philips F. S., Vidal P., Grant A. J., Reichman U., Watanabe K. A., Fox I. J., Chou T. C. 1980; Distribution and metabolic fate of a new antiviral nucleoside: 2′-fiuoro-5-iodo-1-β-arabino-furanosylcytosine (FIAC). Proceedings of the American Association for Cancer Research 21:269
    [Google Scholar]
20. Watanabe K. A., Reichman U., Hioroto K., Lopez C., Fox J. 1979; Nucleosides. 110. Synthesis and antiherpes virus activity of some 5-fluoro-2′-deoxyarabinofuranosylpyrimidine nucleosides. Journal of Medicinal Chemistry 22:21–24
    [Google Scholar]
21. Zavada V., Erban V., Rezacova D., Vonka V. 1976; Thymidine kinase in cytomegalovirus infected cells. Archives of Virology 52:333–339
    [Google Scholar]